AYTU BIOPHARMA INC (AYTU)

US0547548588 - Common Stock

3.08  0 (0%)

After market: 2.94 -0.14 (-4.55%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AYTU BIOPHARMA INC

NASDAQ:AYTU (3/27/2024, 8:01:19 PM)

After market: 2.94 -0.14 (-4.55%)

3.08

0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap17.16M
Shares
PEN/A
Fwd PE6.04
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AYTU Daily chart

Company Profile

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. The company is headquartered in Denver, Colorado and currently employs 150 full-time employees. The company went IPO on 2017-10-20. The Company’s Rx segment consists of prescription pharmaceutical products and the Consumer Health segment consists of various consumer healthcare products (the Consumer Health Portfolio). The Company’s prescription products include Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets for the treatment of attention deficit hyperactivity disorder (ADHD); Karbinal ER (carbinoxamine maleate), an extended-release antihistamine suspension indicated to treat numerous allergic conditions; and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines available in various formulations for infants and children with fluoride deficiency. Its Consumer Health Segment addresses a range of common conditions.

Company Info

AYTU BIOPHARMA INC

7900 E. Union Avenue, Suite 920

Denver COLORADO 80112

P: 17204376580

CEO: Joshua R. Disbrow

Employees: 150

Website: https://aytubio.com/

AYTU News

News Image8 months ago - NewsfileStonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline

Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...

News Image10 months ago - Seeking AlphaAytu prices $4M equity offering (NASDAQ:AYTU)

Aytu BioPharma (AYTU) announced on Friday the pricing of its equity offering of 1.7M shares of its common stock and accompanying Tranche A and Tranche B warrants to purchase 4.3M shares...

News Imagea year ago - InvestorPlaceAYTU Stock Earnings: Aytu Misses EPS, Revenue Estimates

AYTU stock earnings show Aytu Biopharma missing earnings per share and revenue estimates for the fiscal third quarter.

AYTU Twits

Here you can normally see the latest stock twits on AYTU, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example